This inventor holds 1 USPTO granted patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Jamie Knight - Innovator in Therapeutic Compounds
Introduction
Jamie Knight is a prominent inventor based in Slough, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic agents. Her work focuses on compounds that have the potential to treat various diseases, showcasing her dedication to improving healthcare.
Latest Patents
Jamie Knight holds a patent for "Triazolopyridine derivatives and their therapeutic use." This patent describes compounds that act as inhibitors of p38 MAP kinase, which are useful as anti-inflammatory agents in treating diseases of the respiratory tract. The compounds include a variety of structural features, such as C-Calkyl, C-Ccycloalkyl, and phenyl groups, which enhance their therapeutic efficacy.
Career Highlights
Throughout her career, Jamie has been associated with Chiesi Farmaceutici S.p.a., where she has played a crucial role in advancing pharmaceutical research. Her innovative approach to drug development has led to the creation of valuable therapeutic options for patients.
Collaborations
Jamie collaborates with talented professionals in her field, including her coworkers Harry Finch and John Montana. These collaborations foster a creative environment that enhances the development of new and effective therapeutic solutions.
Conclusion
Jamie Knight's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her commitment to advancing healthcare. Her work continues to inspire future innovations in therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile